C. Caparello, “Fixed-Dose Rate Gemcitabine Plus Capecitabine as Second-Line Treatment for Metastatic Pancreatic Cancer Patients Pretreated with Oxaliplatin”, JOP. J Pancreas (Online), vol. 13, no. 5S, p. 596, Sep. 2012.